Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-305.69%
40%
—
43.23%
80%
—
5 Years
Score4.0
Net Growth-305.69%
Net Trend40%
Net Income Consistency—
Rev Growth43.23%
Rev Trend80%
Revenue Consistency—
Supernus Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 520M to $ 718M and net income went from $ 126M to -$ 38M. Revenue increased in 4 of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 144M to $ 718M and net income went from $ 14M to -$ 38M. Revenue increased in 8 of those 10 years; net income in 5.
Supernus Pharmaceuticals Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 47.87 | — |
1 Year2025-08-12 | $ 41.24 | 16.08% |
5 Years2021-08-12 | $ 24.89 | 92.33% |
10 Years2016-08-12 | $ 22.68 | 111.07% |
All Time2012-05-01 | $ 5.37 | 8x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2012-05-01 |
|---|---|---|---|---|---|
| Price | $ 47.87 | $ 41.24 | $ 24.89 | $ 22.68 | $ 5.37 |
| Return | — | 16.08% | 92.33% | 111.07% | 8x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 830M | -$ 109M | $ 372M |
| 2025 | $ 718M | -$ 38M | $ 308M |
| 2024 | $ 661M | $ 73M | $ 453M |
| 2023 | $ 607M | $ 1M | $ 254M |
| 2022 | $ 667M | $ 60M | $ 461M |
| 2021 | $ 579M | $ 53M | $ 339M |
| 2020 | $ 520M | $ 126M | $ 422M |
| 2019 | $ 392M | $ 113M | $ 347M |
| 2018 | $ 408M | $ 110M | $ 356M |
| 2017 | $ 302M | $ 57M | $ 140M |
| 2016 | $ 215M | $ 91M | $ 90M |
| 2015 | $ 144M | $ 14M | $ 62M |
| 2014 | $ 122M | $ 19M | $ 74M |
| 2013 | $ 12M | -$ 92M | $ 82M |
| IPO2012 | $ 1M | -$ 46M | $ 88M |
Explore beyond SUPN
You're looking at Supernus Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
